BCR/ABL MUTATION (RESIST. INHIBIT TYROSINKINASE)

Also known as: BCR/ABL mutation

What you need to know about study BCR/ABL MUTATION (RESIST. INHIBIT TYROSINKINASE)

Sample type Whole blood
Delivery time 10 business days
Do I need to fast? No

What is this study and what is it for?

Evaluation of patients with chronic myelogenous leukemia and Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia receiving treatment with tyrosine kinase inhibitors (TKIs), who are apparently failing treatment. Preferred initial test to identify the presence of acquired BCR-ABL1 mutations associated with TKI resistance.

What type of sample is needed?

Whole blood

Preparation / Instructions

No special indications

Delivery time

10 business days

Get a quote or receive guidance

If you need assistance with a quote, please complete the form and our team will follow up with you:

    Schedule medical tests online

    Schedule your appointment for a time that works best for you, without needing to visit the hospital beforehand.

    Schedule a study

    The information published on this site is for informational and educational purposes. It is not a substitute for medical consultation, professional diagnosis, or treatment prescribed by a specialist. If you have any questions regarding symptoms, test results, or laboratory studies, please consult your doctor.